Interestingly, one current clinical trial is aimed at further identifying and validating the role of GAS5 in prostate cancer through the detection and characterization of GAS5 gene polymorphisms (clinicaltrials.gov; accessed on 29 January 2025 ID: NCT06505356). Here, GAS5 is linked to prostate cancer.